Sort
130,381 grants matching “hiv”
Sample Collection and General Screening Protocols
$2,369,376Lesia Dropulic · National Institute Of Allergy And Infectious Diseases · ZIA · FY2024 · AI
CD4 T cells in anti-viral immunity and immune pathology
$2,368,478Raymond M Welsh · Univ Of Massachusetts Med Sch Worcester · U19 · FY2014 · AI
The HIV-associated Opioid Micro-Environment (HOME) Project
$2,368,125Sara Gianella Weibel · University Of California, San Diego · DP2 · FY2020 · DA
HIV/AIDS Vaccine Development
$2,367,571Gary J Nabel · Niaid Extramural Activities · Z01 · FY2007 · AI
Real-time prediction of emerging drug use epidemics in the United States
$2,367,000Annick Borquez · University Of California, San Diego · DP2 · FY2019 · DA
ENIGMA Center for Worldwide Medicine, Imaging & Genomics
$2,366,897Paul M Thompson · University Of Southern California · U54 · FY2015 · EB
Optimization of HIV vaccines for the induction of cross-reactive antibodies
$2,366,186Shan Lu · Univ Of Massachusetts Med Sch Worcester · U19 · FY2010 · AI
Acute HIV Infection: Implications for vaccine design
$2,366,120Todd M Allen · Massachusetts General Hospital · P01 · FY2012 · AI
PERU Clinical Trial Unit
$2,365,819Jorge Luis Sanchez · Asociacion Civil Impacta Salud Y Educacn · UM1 · FY2023 · AI
Immunopathogenic Mechanisms of Human Immunodeficiency Virus (HIV) Disease
$2,365,134Irini Sereti · National Institute Of Allergy And Infectious Diseases · ZIA · FY2022 · AI
NONHUMAN PRIMATE CORE HUMORAL IMMUNOLOGY LABORATORY FOR AIDS VACCINE RESEARCH AND DEVELOPMENT
$2,365,060David Montefiori · Duke University · N01 · FY2019 · AI
Viral transmission and pathogenesis in human tissues
$2,364,532Leonid B. Margolis · Eunice Kennedy Shriver National Institute Of Child Health & Human Development · ZIA · FY2020 · HD
Rural Drug Addiction Research Center
$2,363,140Rick A Bevins · University Of Nebraska Lincoln · P20 · FY2020 · GM
Enhanced Access to HIV Care for Drug Users in San Juan, Puerto Rico
$2,362,554Lisa R Metsch · Columbia University Health Sciences · R01 · FY2015 · DA
Enhancing Access to Timely Research to Prevent HIV Transmission and Effectively Treat Substance Use
$2,362,500Erika Lynn Crable · University Of California Los Angeles · DP2 · FY2025 · DA
NEW TOOLS FOR EXPLORING THE DYNAMIC INTERACTOME
$2,361,291Michael P Rout · Rockefeller University · U54 · FY2009 · RR
HIV/SIV Data Base and Analysis Unit
$2,361,111Bette Korber · National Institute Of Allergy And Infectious Diseases · Y01 · FY2018 · AI
Center for HIV Identification, Prevention and Treatment Services
$2,361,051Steven Shoptaw · University Of California Los Angeles · P30 · FY2024 · MH
SUPPORT THE IMPLEMENTATION AND EXPANSION OF HIGH QUALITY HIV PREVENTION, CARE AND
$2,360,908Aabid Ahmed · Mkomani Clinic Society · U2G · FY2012 · PS
Strengthening and Expanding rountine HIV counceling & testing & integrating preve
$2,360,000Karen Blyth · Intrahealth International, Inc. · U2G · FY2009 · PS
PS12-1201 COMPREHENSIVE HIV PREVENTION PROJECT FOR HEALTH DEPTS
$2,359,646Veda Latin · Public Health Services · U62 · FY2013 · PS
Discovery of Chemical Probes and Therapeutic Leads, Phase II
$2,359,432Joseph M Fox · University Of Delaware · P20 · FY2022 · GM
Discovery of Chemical Probes and Therapeutic Leads, Phase II
$2,359,432Joseph M Fox · University Of Delaware · P20 · FY2021 · GM
PLCO Trial Etiologic and Early Marker Study
$2,359,239Robert Hoover · Division Of Cancer Epidemiology And Genetics · ZIA · FY2018 · CA
UNC Center for AIDS Research
$2,358,278Ronald I Swanstrom · Univ Of North Carolina Chapel Hill · P30 · FY2006 · AI